Home » Business, Health & Medicine, Manufacturing & Industry, Marketing & Sales, Pharmaceuticals & Biotech » US Generics Market: Industry Trends and Opportunities
“US Generics Market”
A number of factors have catalyzed the strong growth in the US generics market. This includes their low costs, drug patent expiries, cost savings for governments and payers, lower copayments for patients, ageing population and an increasing prevalence of chronic diseases.

The report entitled “US Generics Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the US generics market. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the US generics market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the US generics market in any form.


Key Questions Answered:

  • What are generic drugs and how are they different from branded drugs?
  • How have the US generics market performed in recent years?
  • How have generics performed compared to branded drugs?
  • What were the total sales and prescriptions for generics in the US?
  • Who are the key players in the US generics market and how have they performed?
  • What is the structure of the US generics market?
  • Which are the most prescribed generics in the US?
  • What is the pricing mechanism of generics in the US?
  • What is the value chain of generics in the US?
  • What are the regulations for generics in the US?
  • How are generics distributed in the US?
  • How are generics manufactured?
  • What are the raw material and machinery requirements to manufacture generics?
  • What are the drivers and challenges in the US generics market? 


Table of Contents

1 Research Methodology and Market Definitions
2 Report Summary
3 US Generics Market – Introduction
3.1 What are Generics?
3.2 Unbranded and Branded Generics
3.3 Authorized Generics
3.4 Commoditised and Specialty Generics
4 Why is the US Generics Market so Lucrative
4.1 Patent Expiry of Blockbuster Drugs
4.2 Significant Price Differential Between Generics and Innovator Drugs
4.3 Savings for the Government and Third Party Payers
4.4 Incentives for Dispensing and Prescribing Generics
4.5 Reimbursement and Lower Copayments
4.6 Biosimilars
5 Global Generics Market
5.1 Current and Historical Market Trends
5.2 Market Breakup by Country: The United States Represents the World’s Biggest Market
5.3 Market Forecast
6 US Generics Market
6.1 US Pharmaceutical Market – Current and Historical Market Trends
6.2 US Pharmaceutical Market – Share of Branded and Generic Drugs
6.3 US Generics Market – Current and Historical Sales Trends
6.4 US Generics Market – Current and Historical Volume Trends
6.5 US Generics Market – Market Breakup By Segment
7 US Generics Market- Competitive Landscape
7.1 US Generics Market – Competitive Structure
7.2 US Generics Market – Sales Breakup of Key Players
7.3 US Generics Market – Volume Breakup of Key Players
7.4 US Generics Market – Most Prescribed Generic Drugs
7.5 US Generics Market – Market Breakup By Distribution
7.6 US Generics Market – Pricing Dynamics
8 US Generics Market – Value Chain Analysis
8.1 Research and Development
8.2 Manufacturing
8.3 Marketing and Distribution
9 Regulations in the US Generics Industry
9.1 Overview of Pharmaceutical Regulations
9.2 Drug Applications
9.3 Patents and Market Exclusivity
9.4 Regulatory Requirement For Generics
9.5 The Hatch-Waxman Act
9.6 Possible Certifications
9.7 Other Important Considerations
10 US Generics Market: Key Success Factors
11 US Generics Market: Road Blocks
12 Requirements for Setting Up a Drug Generic Manufacturing Plant
12.1 Manufacturing Process
12.2 Raw Material Requirements
12.3 Machinery and Infrastructure Requirements
13 US Generic Market – Key Company Profiles
13.1 Teva
13.2 Mylan
13.3 Actavis
13.4 Sandoz
13.5 Sun Pharma
13.6 Par Pharmaceuticals
13.7 Endo Pharmaceuticals
13.8 Lupin Pharmaceuticals
13.9 Dr Reddy’s
13.10 Hospira

List of Figures

Figure 3 1: Structure of the Pharmaceutical Industry
Figure 3 2: Classification of Generics
Figure 4 1: United States: Patent Expiry Exposure (in Billion US$), 2009-2018
Figure 4 2: United States: Savings From Generic Drugs (in Billion US$), 2004-2014
Figure 5 1: Global: Generics Market: Sales Value (in Billion US$), 2010-2014
Figure 5 2: Global: Generics Market: Sales Volume (in Billion SU), 2010-2014
Figure 5 3: Global: Generics Market: Sales Value Breakup By Country (in %), 2014
Figure 5 4: Global: Generics Market: Sales Volume Breakup by Country (in %), 2014
Figure 5 5: Global: Generics Market Forecast: Sales Value (in Billion US$), 2015-2020
Figure 5 6: Global: Generics Market: Sales Volume (in Billion SU), 2015-2020
Figure 6 1: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2010-2014
Figure 6 2: US: Pharmaceutical Market: Sales Value (in US$ Billion), 2010-2014
Figure 6 3: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2010 & 2014
Figure 6 4: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2010 & 2014
Figure 6 5: US: Generics Market: Sales Value (in Billion US$), 2010-2014
Figure 6 6: US: Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020
Figure 6 7: US: Generics Market: Sales Volume (in Million Prescriptions), 2010-2014
Figure 6 8: US: Generics Market Forecast: Sales Volume (in Million Prescriptions), 2015-2020
Figure 6 9: US: Generics Market Forecast: Market Breakup by Segment (in %), 2010-2014
Figure 7 1: United States: Generics Market: Sales Share of Top Players (in %), 2014
Figure 7 2: United States: Generics Market: Volume Share of Top Players (in %), 2014
Figure 7 3: United States: Generics Market: Volume Share by Distribution (in %), 2014
Figure 7 4: United States: Generic Drug Prices as a Percentage of Branded Drug Prices – Based on Number of Competitors (in Billion US$)
Figure 8 1: United States – Generics Market – Value Chain Analysis

List of Tables

Table 4 1: United States: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$), 2016-2020
Table 5 1: Global – Generics Market: Sales, Volume and Growth of Major Markets, 2014
Table 7 1: United States: Generics Market: Sales Performance of Top Players (in US$ Million), 2014
Table 7 1: United States: Generics Market: Volume Performance of Top Players (in Million Prescriptions), 2014
Table 7 1: United States: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2014
Table 9 1: United States: Overview of Pharmaceutical Regulations


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099 

IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331 

To know more please visit: http://www.imarcgroup.com/us-generics-market


About IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

To know more about our company, please visit: http://www.imarcgroup.com/

Media Contact
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email: sales@imarcgroup.com
Phone: +91-120-415-5099
Address:G B Nagar Noida Complex
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/

Comments are closed.